Schroder Investment Management Group Has $11.16 Million Holdings in Stryker Corporation (SYK)
Schroder Investment Management Group lessened its holdings in shares of Stryker Corporation (NYSE:SYK) by 50.6% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 79,564 shares of the medical technology company’s stock after selling 81,438 shares during the period. Schroder Investment Management Group’s holdings in Stryker were worth $11,156,000 at the end of the most recent quarter.
Several other large investors have also made changes to their positions in the business. Acrospire Investment Management LLC acquired a new stake in shares of Stryker during the 2nd quarter worth approximately $111,000. Motco lifted its stake in Stryker by 50.7% in the 2nd quarter. Motco now owns 826 shares of the medical technology company’s stock valued at $115,000 after purchasing an additional 278 shares during the last quarter. Bruderman Asset Management LLC bought a new position in Stryker in the 2nd quarter valued at approximately $150,000. James Investment Research Inc. bought a new position in Stryker in the 2nd quarter valued at approximately $155,000. Finally, BB&T Investment Services Inc. bought a new position in Stryker in the 2nd quarter valued at approximately $178,000. Hedge funds and other institutional investors own 74.97% of the company’s stock.
Several equities analysts recently commented on SYK shares. Robert W. Baird raised shares of Stryker from a “neutral” rating to an “outperform” rating and increased their price objective for the company from $161.00 to $173.00 in a research note on Thursday, November 16th. SunTrust Banks reissued a “buy” rating and issued a $161.00 price objective on shares of Stryker in a research note on Friday, November 17th. Wells Fargo & Company increased their price objective on shares of Stryker from $160.00 to $166.00 in a research note on Friday, October 27th. Barclays increased their price objective on shares of Stryker from $137.00 to $148.00 and gave the company an “underweight” rating in a research note on Friday, October 27th. Finally, Oppenheimer reaffirmed a “hold” rating on shares of Stryker in a research note on Wednesday, August 23rd. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and thirteen have assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $152.10.
In other Stryker news, insider Lonny J. Carpenter sold 5,000 shares of the firm’s stock in a transaction on Friday, November 3rd. The shares were sold at an average price of $155.34, for a total value of $776,700.00. Following the completion of the sale, the insider now directly owns 83,207 shares in the company, valued at $12,925,375.38. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 7.40% of the company’s stock.
Stryker Corporation (NYSE:SYK) traded down $0.61 on Friday, hitting $151.15. 1,145,400 shares of the stock traded hands, compared to its average volume of 1,180,981. Stryker Corporation has a 52 week low of $113.00 and a 52 week high of $160.62. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.61 and a current ratio of 2.37. The firm has a market capitalization of $56,794.30, a PE ratio of 24.05, a PEG ratio of 2.39 and a beta of 0.78.
Stryker (NYSE:SYK) last posted its quarterly earnings results on Thursday, October 26th. The medical technology company reported $1.52 EPS for the quarter, topping analysts’ consensus estimates of $1.50 by $0.02. The business had revenue of $3.01 billion during the quarter, compared to analysts’ expectations of $2.97 billion. Stryker had a net margin of 14.67% and a return on equity of 24.11%. The business’s quarterly revenue was up 6.1% on a year-over-year basis. During the same period last year, the company posted $1.39 earnings per share. equities research analysts anticipate that Stryker Corporation will post 6.47 EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “Schroder Investment Management Group Has $11.16 Million Holdings in Stryker Corporation (SYK)” was originally reported by Daily Political and is the property of of Daily Political. If you are accessing this news story on another website, it was illegally copied and republished in violation of US & international copyright & trademark law. The legal version of this news story can be read at https://www.dailypolitical.com/2017/12/08/schroder-investment-management-group-has-11-16-million-holdings-in-stryker-corporation-syk.html.
Stryker Company Profile
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.